Teva Pharmaceutical Industries Profit Margin 2006-2018 | TEVA
Current and historical gross margin, operating margin and net profit margin for Teva Pharmaceutical Industries (TEVA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Teva Pharmaceutical Industries net profit margin as of September 30, 2018 is -54.67%.
|Teva Pharmaceutical Industries Annual Profit Margins
|Teva Pharmaceutical Industries Quarterly Profit Margins
||Medical - Generic Drugs
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.